Clinical Trials Logo

Clinical Trial Summary

The proposed randomized controlled trial will evaluate the effects of treadmill training augmented with virtual reality on fall risk.

300 older adults with a history of falls will be recruited to participate in this study. This will include older adults (n=100), patients with mild cognitive impairment (MCI) (n=100), and patients with Parkinson's disease (PD)(n=100). Subjects will be randomly assigned to the intervention group (treadmill training with virtual reality) or to the active-control group (treadmill training without virtual reality). Each person will participate in a training program set in an outpatient setting 3 times per week for 6 weeks. Assessments will take place before, after, and 1 month and 6 months after the completion of the training.


Clinical Trial Description

A prospective, single blinded, parallel group, randomized controlled trial with 6 month follow-up will be employed to investigate the effects of treadmill training augmented with virtual reality on fall risk. The study will include 300 older participants who have experienced two or more falls in the previous 6 months. Participants will be randomized to either the intervention or control group. The intervention group will receive 18 sessions of Treadmill Training with Virtual Reality (TT+VR) and the active control comparison will receive 18 training sessions of treadmill training alone (TT) without the VR simulation All interventions will be delivered by therapists trained in the standard protocols. All subjects will be trained 3 times a week for 6 weeks, each session will last approximately 45 minutes.Training progression will be based on increasing both motor and cognitive challenges, individualized to the participant's level of performance.

Primary outcome measures:

The primary outcome measure of the study is fall rate for 6 months post intervention. Secondary outcome measures will include gait speed and gait variability under usual and dual task conditions and while negotiating physical obstacles will be measured. Endurance will be assessed using the 2 Minute Walk Test and mobility will be assessed using the Four Square Step Test (FSST), The Short Physical Performance Battery (SPPB) and the mini-Balance Evaluation Systems Test (mini-BESTest). Community ambulation will be assessed using a tri-axial accelerometer ('Axivity' Ltd.)which will be worn by the participants for 7 days. Cognitive function will be assessed using a computerized neuropsychological test battery (Mindstreams, 'NeuroTrax' Corp., NJ) as well as standardized neuropsychological tests (Montreal Cognitive Assessment,The Trail Making Test; Verbal Fluency). Quality of life will be evaluated using the SF-36 Health Survey ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01732653
Study type Interventional
Source Tel-Aviv Sourasky Medical Center
Contact
Status Completed
Phase N/A
Start date November 2012
Completion date December 2015

See also
  Status Clinical Trial Phase
Completed NCT06037590 - A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops™ Relative to INBRIJA® Phase 1
Recruiting NCT01537224 - Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information N/A
Withdrawn NCT04011449 - State-dependent Pathophysiological Oscillations in Parkinson's Disease and Treatment With DBS Using the Medtronic RC+S N/A
Completed NCT02539446 - Suprapostural Attention Focus and Postural Difficulty on H-reflex and Brain Activity: Aging and Parkinson's Disease N/A
Completed NCT00358189 - Effects of Deep Brain Stimulation for the Treatment of Parkinson's Disease N/A
Active, not recruiting NCT04606979 - tDCS of the Primary Motor Cortex to Improve Implicit Motor Sequence Learning in Parkinson's Disease N/A
Completed NCT05119803 - The Relationship of Spine Posture and Mobility With Upper Extremity Functions in Parkinson's Patients
Recruiting NCT06154772 - Quality of Life, Anxiety and Fatigue Level of Parkison's Patients With Color Therapy N/A
Not yet recruiting NCT02249715 - Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease N/A
Completed NCT03232996 - Evaluation of a Computer Game Based Rehabilitation System for Assessment and Treatment of Balance and Gait Impairments in Individuals With Parkinson's Disease. N/A
Enrolling by invitation NCT04566341 - Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's Disease
Active, not recruiting NCT04978597 - Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study) Phase 3
Recruiting NCT06116084 - Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine N/A
Recruiting NCT05830396 - GRoningen Early-PD Ambroxol Treatment Phase 2/Phase 3
Not yet recruiting NCT05379062 - Choral Singing for Patients With Parkinson's N/A
Completed NCT02071823 - Comparative Bioavailability Study of BIA 9-1067 25 mg Capsules Phase 1
Recruiting NCT03558568 - The Effect of Deep Brain Stimulation on Facial Expressions. N/A
Enrolling by invitation NCT05596201 - Super-resolution of Brain Magnetic Resonance Images in Deep Brain Stimulation for Parkinson's Disease
Recruiting NCT04181918 - Action Observation Treatment in Parkinson's Patients N/A
Completed NCT02305277 - Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers Phase 1